JENNIFER CARRICO: Open Payments
NPI 1114383981 · MAYFIELD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,268 in 64 payments from 17 companies in 2025. Trend: 2023 $1,342 · 2024 $1,611 · 2025 $1,268
Food & beverage: $1,268
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $371 |
| GlaxoSmithKline, LLC. | 13 | $219 |
| Regeneron Healthcare Solutions, Inc. | 5 | $94 |
| Viatris Specialty LLC | 5 | $76 |
| Verona Pharma, Inc. | 4 | $75 |
| United Therapeutics Corporation | 4 | $71 |
| Insmed, Inc. | 3 | $70 |
| GENZYME CORPORATION | 3 | $55 |
| Grifols USA, LLC | 2 | $44 |
| Baxter Healthcare | 2 | $35 |
Products named: BREZTRI, DUPIXENT, TRELEGY ELLIPTA, NUCALA, YUPELRI, Ohtuvayre, Tyvaso, Arikayce.
Industry payments across KY — which companies pay providers there.
